Adial Pharmaceuticals, Inc. Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling after Year Five
Adial Pharmaceuticals, Inc. (ADIL) had Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling after Year Five of $6.51 thousand as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Notes › Leases
us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsDueInRollingAfterYearFive · last filed 2021-05-17
- 2021-03-31: Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling after Year Five $6.51K.
| Period end | Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling after Year Five |
|---|---|
| 2021-03-31 | $6.51K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |